Showing 201 - 220 results of 1,123 for search '"prostate"', query time: 0.08s Refine Results
  1. 201

    Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy by Alberto Sánchez Garrido, Guido Nino Guida Acevedo, Becker Neto Mullo

    Published 2024-01-01
    “…<strong>Foundation:</strong> prostate cancer is a common oncological condition in men. …”
    Get full text
    Article
  2. 202
  3. 203
  4. 204

    Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer by Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, Tunc Morova, Chia-Chi Flora Huang, Betul Ersoy Fazlioglu, Ivan Pak Lok Yu, Batuhan M. Kalkan, Paloma Cejas, Sonia H. Y. Kung, Ladan Fazli, Akane Kawamura, Henry W. Long, Ceyda Acilan, Tamer T. Onder, Tugba Bagci-Onder, James T. Lynch, Nathan A. Lack

    Published 2025-02-01
    “…Abstract Enzalutamide is a potent second-generation antiandrogen commonly used to treat hormone-sensitive and castration-resistant prostate cancer (CRPC) patients. While initially effective, the disease almost always develops resistance. …”
    Get full text
    Article
  5. 205
  6. 206

    Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men by Rustom P. Manecksha, Gregory J. Nason, Ivor M. Cullen, Jérôme P. Fennell, Elizabeth McEvoy, Ted McDermott, Robert J. Flynn, Ronald Grainger, John A. Thornhill

    Published 2012-01-01
    “…We aimed to compare infection rates for two 3-day antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy (TRUSgbp) and demonstrate local microbiological trends. …”
    Get full text
    Article
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212

    Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence by Youcef Derbal

    Published 2025-01-01
    “…This article presents a hypothetical case study on the application of generative pre-trained transformers (GPTs) to the treatment of metastatic prostate cancer (mPC). The case explores the design of GPT-supported adaptive intermittent therapy for mPC. …”
    Get full text
    Article
  13. 213
  14. 214
  15. 215

    Case Report of Synchronous Prostate, Hepatocellular, and Rectal Carcinomas and Review of the Literature by Viktoria Lamprou, Daniel Paramythiotis, Dimitrios Giakoustidis, Anestis Karakatsanis, Athanasios Astreinidis, Moysis Moysidis, Antonios Mihalopoulos, Stefanos Finitsis

    Published 2020-01-01
    “…We report a case of synchronous prostate, hepatocellular, and rectal carcinomas and discuss our therapeutic strategy that resulted in excellent clinical results.…”
    Get full text
    Article
  16. 216
  17. 217

    Gαs Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer by Lijuan Wang, Guihua Jin, Chenchen He, Xijing Guo, Xia Zhou, Meng Li, Xia Ying, Le Wang, Huili Wu, Qing Zhu

    Published 2014-01-01
    “…Gαs expression was semiquantitatively scored and evaluated the correlation with pathologic parameters and biochemical recurrence of prostate-specific antigen (PSA). Results. Gαs expression was localized in nuclear and cytoplasm in prostate cancer cells and downregulated in metastatic PCa compared to localized PCa and BPH (P<0.001). …”
    Get full text
    Article
  18. 218

    Deep unsupervised clustering for prostate auto-segmentation with and without hydrogel spacer by Hengrui Zhao, Biling Wang, Michael Dohopolski, Ti Bai, Steve Jiang, Dan Nguyen

    Published 2025-01-01
    “…In recent years, hydrogel spacers have been used in some prostate cancer patients receiving radiotherapy to separate the prostate and the rectum to better spare the rectum while achieving adequate dose coverage on the prostate. …”
    Get full text
    Article
  19. 219
  20. 220